Purchase Order 12405B21P0109

Award Date 2/3/21
Potential Completion Date 3/1/21
Potential Value $25K
Federal Agency
Southeast Area
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Athens, GA 30605, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Office of Naval Research (ONR) awarded a $247,955.00 firm fixed-price purchase order to DNA Script Inc., a foreign-owned, for-profit company based in Daly City, California. The contract is for the procurement of a Syntax Model STX-200 DNA synthesizer system, associated on-premises console software, and a laptop bundle. This sole-source procurement was conducted under Simplified Acquisition Procedures and did not have a set-aside designation. The contract supports critical research...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to GenScript USA Inc., a biotechnology company based in New Jersey. The contract is for the supply of synthetic DNA sequences for cell culture expression of monoclonal antibodies to mumps virus, with a ceiling value of $75,024.01 and a period of performance through April 28, 2020. The award was made using a sole-source authority, as the government determined GenScript was the only source...
Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $356,221 firm fixed price purchase order to Synthego Corporation, located in Redwood City, California. Synthego will deliver one Whole Human Genome Arrayed CRISPR Screening Library to the National Institutes of Health campus in Rockville, Maryland by September 3, 2021. The library, as requested in the solicitation, will contain up to three chemically modified synthetic sgRNAs per well targeting...
This federal contract award is for the purchase of one (1) Syntax System Model 200 instrument for the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Production Program (VPP). The total ceiling value of the firm-fixed-price purchase order is $342,026.40. The contractor, DNA Script Inc., is a foreign-owned for-profit business that provides advanced DNA synthesis technologies and associated products and services to U.S. government agencies. This procurement was not set...
This is a $11,692.01 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Synbio Technologies LLC, a minority-owned, for-profit, Asian-Pacific American-owned limited liability company. The contract is for gene synthesis and testing services, to be performed in Monmouth Junction, South Brunswick Township, New Jersey. The contract has an April 25,...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed price purchase order to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 1,536 antisense oligonucleotides targeting the CHCHD10 gene. The $102,915.50 contract has an August 29, 2022 completion date and does not have a set-aside designation. IDT is a manufacturer of nucleic acid products that has previously supported...
This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $248,857.00 Firm Fixed Price purchase order to Genscript USA Inc., a biotechnology company, for the provision of "FAST GENE SYNTHESIS" services. The contract has an August 7, 2023 completion date and was awarded on August 8, 2022. Genscript is a for-profit organization that provides gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to...

SYNTHETIC DNA

Posted 2/3/21, 12:00 AM